ListarInvestigación y Desarrollo por tema "Angiotensin receptor antagonists"
Mostrando ítems 1-1 de 1
-
Article
Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database (2021)
(Elsevier Ltd, 2021-05)Introduction: We explored the potential clinical effects of angiotensin-II AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) in patients from the Parkinson's Progress Marker Initiative (PPMI) ...